INTRACT PHARMA LIMITED
Significant control: Vipul Yadav (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Intract Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Intract Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
INTRACT PHARMA LIMITED is an active private limited company (company number 09610219) incorporated on 27 May 2015, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 May 2025, showing net assets of £1.29m and cash of £1.35m, with 9 employees on average. Net assets rose 335% on the prior period (£296k).
By net assets it sits in the top quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
- Dr Vipul Yadav
- has significant influence or control
- William Pirie Lindsay
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 27 May 201511 yrs ago
- Next accounts due
- 28 February 2027in 127 days
- Confirmation statement due
- 10 June 2027in 229 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £1.29m | £1.35m | — | £195k | — | — | 9 |
| 31 May 2024 | £296k | £236k | — | £36k | — | — | 6 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £1,288,133 at 31 May 2025
- Net assets up 10% or more on the prior period+335.3% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 7.11
- Cash at bank of £50,000 or moreCash £1,353,508
- Incorporated five or more years agoIncorporated 27 May 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 229 days
- Next accounts duein 127 days
- Accounts period endNet assets £1.29m · small accounts
- Accounts period endNet assets £296k · small accounts
- Incorporated
Similar companies in Cambridge
- CAMBRIDGE MOLECULAR DIAGNOSTICS LTDCambridge · inc. May 2015
- BIOS HEALTH LTDCambridge · inc. May 2015
- STORM THERAPEUTICS LIMITEDWaterbeach · inc. Apr 2015
- SELVITA LIMITEDCambridge · inc. Apr 2015
- METRION BIOSCIENCES LTDCambridge · inc. Jul 2015
- WATERSCOPE LIMITEDCambridge · inc. Jul 2015
All companies incorporated on 27 May 2015 · in May 2015.
Reminders for INTRACT PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.